Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy

被引：0
|
作者：
Ismail Sari
Omer Binicier
Merih Birlik
Servet Akar
Erkan Yilmaz
Aydanur Kargi
Fatos Onen
Nurullah Akkoc
机构：
[1] Dokuz Eylul University School of Medicine,Department of Internal Medicine, Division of Rheumatology
[2] Dokuz Eylul University School of Medicine,Department of Radiology
[3] Dokuz Eylul University School of Medicine,Department of Pathology
[4] Dokuz Eylul Universitesi Tip Fakultesi Ic hastaliklari ABD Immunoloji-Romatoloji,undefined
来源：
Rheumatology International | 2009年 / 29卷
关键词：
Tumor necrosis factor alpha inhibitors; Adverse effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tumor necrosis factor (TNF) alpha inhibitors are effective in the treatment of inflammatory rheumatic diseases. Despite their effectiveness, anti-TNF drugs have some drawbacks such as severe adverse effects including infections and possibly lymphoproliferative disorders. In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement (true thymic hyperplasia), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under Etanercept treatment. The clinical presentation was highly suggestive of malignancy and the patient underwent diagnostic mediastinoscopy with biopsy.
引用
收藏
相关论文
共 50 条
  • [21] Response to Etanercept in Juvenile Idiopathic Arthritis Reply
    Otten, Marieke H.
    Prince, Femke H. M.
    van Suijlekom-Smit, Lisette W. A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (11): : 1140 - 1141
  • [22] ETANERCEPT CONCENTRATION IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Karki, J.
    Levalampi, T.
    Vahasalo, P.
    Backstrom, M.
    Kroger, L.
    Malin, M.
    Putto-Laurila, A.
    Pohjankoski, H.
    Kautiainen, H.
    Jokiranta, S.
    Aalto, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1196 - 1197
  • [23] Etanercept and uveitis in patients with juvenile idiopathic arthritis
    Schmeling, H
    Horneff, G
    RHEUMATOLOGY, 2005, 44 (08) : 1008 - 1011
  • [24] ETANERCEPT RESPONSE CLUSTERS IN JUVENILE IDIOPATHIC ARTHRITIS
    Shoop-Worrall, S.
    Hyrich, K.
    Wedderburn, L.
    Thomson, W.
    Geifman, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 97 - 98
  • [25] Etanercept in juvenile idiopathic arthritis: Who will benefit?
    MH Otten
    FHM Prince
    W Armbrust
    R ten Cate
    EPAH Hoppenreijs
    M Twilt
    Y Koopman-Keemink
    SL Gorter
    KM Dolman
    JF Swart
    JM van den Berg
    NM Wulffraat
    MAJ van Rossum
    LWA van Suijlekom-Smit
    Pediatric Rheumatology, 9 (Suppl 1)
  • [26] Etanercept and uveitis in patients with juvenile idiopathic arthritis
    Schmeling, H
    Winkler, A
    Horneff, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 384 - 384
  • [27] Etanercept and urticaria in patients with juvenile idiopathic arthritis
    Skyttä, E
    Pohjankoski, H
    Savolainen, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (04) : 533 - +
  • [28] Efficacy of etanercept in the treatment of juvenile idiopathic arthritis
    de Inocencio Arocena, J.
    Merino Munoz, R.
    Alvarez Madrid, C.
    Garcia-Consuegra Molina, J.
    ANALES DE PEDIATRIA, 2009, 70 (04): : 354 - 361
  • [29] Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis
    Berard, Roberta A.
    Laxer, Ronald M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (11) : 1623 - 1630
  • [30] Challenges in the management of juvenile idiopathic arthritis with etanercept
    Pain, Clare E.
    McCann, Liza J.
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 127 - 139
12345